Boardroom Alpha
10-Q primary document
ROP · Quarterly Report (Form 10-Q) · Filed August 1, 2025

Roper Technologies Inc10-Q exhibit

a2025ropernon-employeedire.htm
Document

ROPER TECHNOLOGIES, INC.
2021 Incentive Plan
UNRESTRICTED STOCK AWARD AGREEMENT
Pursuant to this Unrestricted Stock Award Agreement (this “Award Agreement”), and subject to the terms and conditions herein and in the Roper Technologies, Inc. 2021 Incentive Plan (the “Plan”), Roper Technologies, Inc. (the “Company”) grants, pursuant to Article 10 of the Plan, an Award of Unrestricted Stock to the following identified Grantee in consideration of the Grantee’s service as a Non-Employee Director with the following specified terms:
Summary of Award Terms:
Name of Non-Employee Director: _____________ (the “Grantee”)
Date of Grant: _______________ (the “Grant Date”)
Number of Shares of Unrestricted Stock: ________________ (the “Shares”)
Vesting: The Shares are fully vested on the Grant Date.
Capitalized terms used in this Award Agreement, unless otherwise defined, shall have the meanings set forth in the Plan.
1.Rights of a Stockholder. As of the Grant Date, the grantee shall have all of the rights of a stockholder of the Company with respect to the Shares (including voting rights and the right to receive dividends and other distributions). The Company may evidence the Grantee’s Shares by using a book entry account with the Company’s transfer agent.
2.No Right to Continued Service. This Award Agreement does not give the Grantee a right to continued service as a Non-Employee Director.
3.Administration; Interpretation. In accordance with the Plan and this Award Agreement, the Committee shall have full discretionary authority to administer the Award, including discretionary authority to interpret and construe any and all provisions relating to the Award. Decisions of the Committee shall be final, binding, and conclusive on all parties.
4.Successors. The terms of this Award Agreement shall be binding upon and inure to the benefit of the heirs of the Grantee or distributees of the Grantee’s estate and any successor to the Company.



5.Governing Law. This Award Agreement shall be construed and administered in accordance with the laws of the State of Delaware without regard to its conflict of law principles.
6.Acknowledgment of Receipt and Acceptance. By signing below (or acceptance by other means, including by electronic signature), the Grantee acknowledges receipt and acceptance of the Award, agrees to the terms of the Award, and indicates the Grantee’s intention to be bound by this Award Agreement and the terms of the Plan.
2
1104089598\1\
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer